ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.69
+0.06 (1.07%)
Aug 7, 2026, 4:00 PM EDT - Market closed
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $64.18 million as of August 10, 2026. Its market cap has decreased by -63.56% in one year.
Market Cap
64.18M
Enterprise Value
-70.06M
1-Year Change
-63.56%
Ranking
Category
Stock Price
$5.69
ChartMarket Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $64.18M, a decrease of -64.94%. That is a compound annual growth rate of -63.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 64.18M | -16.82% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 70.05M |
| Rein Therapeutics | 69.93M |
| XBiotech | 69.21M |
| Alps Group | 69.07M |
| Cardiff Oncology | 67.82M |
| MediciNova | 65.96M |
| Pliant Therapeutics | 65.02M |
| Boundless Bio | 64.92M |